How should suspected organophosphate poisoning be managed in the field according to typical EMS protocols?

• A. Decontaminate only
• B. Administer Naloxone
• C. No decontamination
• D. Decontaminate, monitor airway; administer atropine and pralidoxime as per protocol; transport promptly for advanced care

Answer: (D)

Field management of suspected organophosphate poisoning centers on preventing further exposure, protecting the airway, giving the appropriate antidotes, and getting the patient to definitive care quickly.

Decontamination is essential first to stop ongoing absorption and to prevent the contaminating agent from spreading to responders and the vehicle. At the same time, airway protection is critical because organophosphates drive a cholinergic crisis that causes excessive secretions, bronchospasm, and respiratory failure; continuous assessment, suctioning, oxygen administration, and readiness for airway support are needed.

The specific antidotes are atropine and pralidoxime. Atropine counteracts the muscarinic effects (salivation, bronchorrhea, bronchospasm, bradycardia), while pralidoxime reactivates acetylcholinesterase, addressing both muscarinic and nicotinic symptoms (including muscle weakness). Administering these per the EMS protocol is essential rather than relying on decontamination alone or on unrelated treatments.

Transport to a facility with advanced care should be prompt so that ongoing antidotal therapy and monitoring can continue, and the patient can receive specialized care if deterioration occurs.

Naloxone is not a primary treatment for organophosphate poisoning, as it targets opioid overdose, not the cholinergic crisis caused by organophosphates.